103106-22-5 (2H-萘并[2,3-b]吡喃-5,10-二酮,10a-[(3-溴-2,2-二甲基-6-亚甲基环己基)甲基]-3,4a-二氯-3,4,4a,10a-四氢-6,8-二羟基-2,2-二甲基-(9CI),2H-Naphtho[2,3-b]pyran-5,10-dione,10a-[(3-bromo-2,2-dimethyl-6-methylenecyclohexyl)methyl]-3,4a-dichloro-3,4,4a,10a-tetrahydro-6,8-dihydroxy-2,2-dimethyl-(9CI))

CAS号:
103106-22-5
中文名称:
2H-萘并[2,3-b]吡喃-5,10-二酮,10a-[(3-溴-2,2-二甲基-6-亚甲基环己基)甲基]-3,4a-二氯-3,4,4a,10a-四氢-6,8-二羟基-2,2-二甲基-(9CI)
英文名称:
2H-Naphtho[2,3-b]pyran-5,10-dione,10a-[(3-bromo-2,2-dimethyl-6-methylenecyclohexyl)methyl]-3,4a-dichloro-3,4,4a,10a-tetrahydro-6,8-dihydroxy-2,2-dimethyl-(9CI)
分子式:
C25H29BrCl2O5
分子量:
560.304765462875

2H-萘并[2,3-b]吡喃-5,10-二酮,10a-[(3-溴-2,2-二甲基-6-亚甲基环己基)甲基]-3,4a-二氯-3,4,4a,10a-四氢-6,8-二羟基-2,2-二甲基-(9CI)(103106-22-5)名称与标识符

名称

英文别名:
2H-Naphtho[2,3-b]pyran-5,10-dione,10a-[(3-bromo-2,2-dimethyl-6-methylenecyclohexyl)methyl]-3,4a-dichloro-3,4,4a,10a-tetrahydro-6,8-dihydroxy-2,2-dimethyl-(9CI);(3R,10aS)-10a-[(1R,3S)-3-bromo-2,2-dimethyl-6-methylidenecyclohexyl]oxy-3,4a-dichloro-6,8-dihydroxy-2,2-dimethyl-3,4-dihydrobenzo[g]chromene-5,10-dione;2H-Naphtho[2,3-b]pyran-5,10-dione,10a-[(3-bromo-2,2-dimethyl-6-methylenecyclohexyl)methyl]-3,4...;2H-Naphtho[2,3-b]pyran-5,10-dione,10a-[(3-bromo-2,2-dimethyl-6-methylenecyclohexyl)methyl]-3,4a-dichloro-3,4,4a,10a-tetrahydr;3,4a-Dichloro-6,8-dihydroxy-3,4,4a,10a-tetrahydro-2,2-dimethyl-10a-[(2,2-dimethyl-3-bromo-6-methylenecyclohexyl)methyl]-2H-naphtho[2,3-b]pyran-5,10-dione;AntibioticMG 802AF2B3;MG 802AF2B3;Napyradiomycin B 3;MG-802AF2B3;Napyradiomycin B3;Antibiotic MG-802AF2B3;(3R,4aR,10aS)-10a-[[(1R,3S)-3-bromo-2,2-dimethyl-6-methylidenecyclohexyl]methyl]-3,4a-dichloro-6,8-dihydroxy-2,2-dimethyl-3,4-dihydrobenzo[g]chromene-5,10-dione;103106-22-5;VA34YQT845;Antibiotic MG 802AFB3;2H-NAPHTHO(2,3-B)PYRAN-5,10-DIONE, 10A-((3-BROMO-2,2-DIMETHYL-6-METHYLENECYCLOHEXYL)METHYL)-3,4A-DICHLORO-3,4,4A,10A-TETRAHYDRO-6,8-DIHYDROXY-2,2-DIMETHYL-;CHEBI:223531;Q27291718;UNII-VA34YQT845;CHEMBL3104844;2H-Naphtho(2,3-b)pyran-5,10-dione, 3,4,4a,10a-tetrahydro-10a-((3-bromo-2,2-dimethyl-6-methylenecyclohexyl)methyl)-6,8-hydroxy-2,2-dimethyl-;10a-[(3-Bromo-2,2-dimethyl-6-methylidenecyclohexyl)oxy]-3,4a-dichloro-6,8-dihydroxy-2,2-dimethyl-3,4,4a,10a-tetrahydro-2H-naphtho[2,3-b]pyran-5,10-dione;DTXSID10908200;

标识符

InChIKey:
PVEFIGXLPBGZAX-RVRKADHMSA-N
Inchi:
1S/C25H29BrCl2O5/c1-12-6-7-17(26)22(2,3)15(12)10-25-20(31)14-8-13(29)9-16(30)19(14)21(32)24(25,28)11-18(27)23(4,5)33-25/h8-9,15,17-18,29-30H,1,6-7,10-11H2,2-5H3/t15-,17+,18-,24+,25+/m1/s1
SMILES:
Br[C@H]1CCC(=C)[C@H](C1(C)C)C[C@]12C(C3C=C(C=C(C=3C([C@]1(C[C@H](C(C)(C)O2)Cl)Cl)=O)O)O)=O

2H-萘并[2,3-b]吡喃-5,10-二酮,10a-[(3-溴-2,2-二甲基-6-亚甲基环己基)甲基]-3,4a-二氯-3,4,4a,10a-四氢-6,8-二羟基-2,2-二甲基-(9CI)(103106-22-5)物化性质

实验特性

  • PSA : 93.06

计算特性

  • 精确分子量 : 560.03691
  • 氢键供体数量 : 2
  • 氢键受体数量 : 5
  • 可旋转化学键数量 : 2
  • 同位素质量 : 558.05754g/mol
  • 重原子数量 : 33
  • 复杂度 : 875
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 5
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 6
  • 拓扑分子极性表面积 : 83.8Ų

2H-萘并[2,3-b]吡喃-5,10-二酮,10a-[(3-溴-2,2-二甲基-6-亚甲基环己基)甲基]-3,4a-二氯-3,4,4a,10a-四氢-6,8-二羟基-2,2-二甲基-(9CI)(103106-22-5)相关文献